The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review
Abstract
Hypoxia is a salient feature observed in most solid malignancies that holds a pivotal role in angiogenesis, metastasis and resistance to conventional cancer therapeutic approaches, and thus enables cancer progression. However, the typical characteristics of hypoxic cells such as low oxygen levels and highly bio-reductive environment can offer stimuli-responsive drug release to aid in tumor-specific chemo, radio, photodyanamic and sonodynamic therapies. This approach based on targeting the poorly oxygenated tumor habitats offers the prospective to overcome the difficulties that arises due to heterogenic nature of tumor and could be possibly used in the design of diagnostic as well as therapeutic nanocarriers for targeting various types of solid cancers. Consequently, hypoxia triggered nanoparticle based drug delivery systems is a rapidly progressing research area in developing effective strategies to combat drug-resistance in solid tumors. The present review presents the recent advances in the development of hypoxia-responsive nanovehicles for drug delivery to heterogeneous tumors. The initial sections of the article provides insights into the development of hypoxia in growing cancer and its role in disease progression. The current limitations and the future prospective of hypoxia-stimulated nanomachines for cancer treatment are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlled growth of monodisperse silica spheres in the micron size range
Stöber, W., Fink, A., & Bohn, E. (1968) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(68)90272-5 · Cited by 14,532
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Photodynamic therapy for cancer
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1071 · Cited by 6,758
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., & Peng, Q. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.889 · Cited by 4,716
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Gomer, C. J. (1988) · Cited by 4,174
Ritger, P. L., & Peppas, N. A. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90034-4 · Cited by 3,830
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Silica‐Based Mesoporous Organic–Inorganic Hybrid Materials
Hoffmann, F., Cornelius, M., Morell, J., & Fröba, M. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503075 · Cited by 3,089
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Stimuli-reponsive polymers and their bioconjugates
GIL, E., & HUDSON, S. (2004) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2004.08.003 · Cited by 2,385
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
The cancer stem cell: premises, promises and challenges
Clevers, H. (2011) · Nature Medicine · doi:10.1038/nm.2304 · Cited by 1,923
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Biodegradation, biodistribution and toxicity of chitosan
Kean, T., & Thanou, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.004 · Cited by 1,837
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Li, D., Xie, K., Wolff, R., & Abbruzzese, J. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15841-8 · Cited by 1,719
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., & Liu, L. F. (1984) · Science · doi:10.1126/science.6093249 · Cited by 1,538
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Gilkes, D. M., Semenza, G. L., & Wirtz, D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3726 · Cited by 1,520
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design
Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C., & Chan, W. C. W. (2009) · Nano Letters · doi:10.1021/nl900031y · Cited by 1,513
Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Gupta, P. B., Fillmore, C. M., Jiang, G., Shapira, S. D., Tao, K., Kuperwasser, C., & Lander, E. S. (2011) · Cell · doi:10.1016/j.cell.2011.07.026 · Cited by 1,475
In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers
Idris, N. M., Gnanasammandhan, M. K., Zhang, J., Ho, P. C., Mahendran, R., & Zhang, Y. (2012) · Nature Medicine · doi:10.1038/nm.2933 · Cited by 1,464
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery
Cheng, R., Meng, F., Deng, C., Klok, H.-A., & Zhong, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.084 · Cited by 1,354
Bae, Y., Fukushima, S., Harada, A., & Kataoka, K. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200250653 · Cited by 1,329
Patient-derived tumour xenografts as models for oncology drug development
Tentler, J. J., Tan, A. C., Weekes, C. D., Jimeno, A., Leong, S., Pitts, T. M., Arcaroli, J. J., Messersmith, W. A., & Eckhardt, S. G. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.61 · Cited by 1,277
(1996) · PubMed · Cited by 1,188
Charafe-Jauffret, E., Ginestier, C., Iovino, F., Wicinski, J., Cervera, N., Finetti, P., Hur, M.-H., Diebel, M. E., Monville, F., Dutcher, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2741 · Cited by 1,173
ROS homeostasis and metabolism: a dangerous liason in cancer cells
Panieri, E., & Santoro, M. M. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.105 · Cited by 1,151
A dual-emissive-materials design concept enables tumour hypoxia imaging
Zhang, G., Palmer, G. M., Dewhirst, M. W., & Fraser, C. L. (2009) · Nature Materials · doi:10.1038/nmat2509 · Cited by 1,150
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Chaffer, C. L., Brueckmann, I., Scheel, C., Kaestli, A. J., Wiggins, P. A., Rodrigues, L. O., Brooks, M., Reinhardt, F., Su, Y., Polyak, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102454108 · Cited by 1,147
Trewyn, B. G., Slowing, I. I., Giri, S., Chen, H.-T., & Lin, V. S.-Y. (2007) · Accounts of Chemical Research · doi:10.1021/ar600032u · Cited by 1,123
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
Wheaton, W. W., Weinberg, S. E., Hamanaka, R. B., Soberanes, S., Sullivan, L. B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G. M., Budigner, G. S., et al. (2014) · eLife · doi:10.7554/elife.02242 · Cited by 1,105
Clement, V., Sanchez, P., de Tribolet, N., Radovanovic, I., & Ruiz i Altaba, A. (2007) · Current Biology · doi:10.1016/j.cub.2006.11.033 · Cited by 1,050
Hypoxic enhancement of exosome release by breast cancer cells
King, H. W., Michael, M. Z., & Gleadle, J. M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-421 · Cited by 1,045
Ernsting, M. J., Murakami, M., Roy, A., & Li, S.-D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.013 · Cited by 1,012
Vaupel, P. W., Schlenger, K., Knoop, C., & Höckel, M. (1991) · PubMed · Cited by 952
Intracellular Glutathione Detection Using MnO2-Nanosheet-Modified Upconversion Nanoparticles
Deng, R., Xie, X., Vendrell, M., Chang, Y.-T., & Liu, X. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2100774 · Cited by 936
Qian, X., Zheng, Y., & Chen, Y. (2016) · Advanced Materials · doi:10.1002/adma.201602012 · Cited by 882
Yu, J., Zhang, Y., Ye, Y., DiSanto, R., Sun, W., Ranson, D., Ligler, F. S., Buse, J. B., & Gu, Z. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505405112 · Cited by 848
Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia
Liu, J.-N., Bu, W., & Shi, J. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00525 · Cited by 838
Chen, H., Tian, J., He, W., & Guo, Z. (2015) · Journal of the American Chemical Society · doi:10.1021/ja511420n · Cited by 813
Strategies for advancing cancer nanomedicine
Chauhan, V. P., & Jain, R. K. (2013) · Nature Materials · doi:10.1038/nmat3792 · Cited by 812
Photodynamic Therapy in Oncology
Triesscheijn, M., Baas, P., Schellens, J. H. M., & Stewart, F. A. (2006) · The Oncologist · doi:10.1634/theoncologist.11-9-1034 · Cited by 737
Hypoxia and Metabolic Adaptation of Cancer Cells
Eales, K. L., Hollinshead, K. E. R., & Tennant, D. A. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.50 · Cited by 724
Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy
Li, H.-J., Du, J.-Z., Du, X.-J., Xu, C.-F., Sun, C.-Y., Wang, H.-X., Cao, Z.-T., Yang, X.-Z., Zhu, Y.-H., Nie, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522080113 · Cited by 724
Hypoxia and hypoxia-inducible factors: master regulators of metastasis
Lu, X., & Kang, Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1360 · Cited by 723
Derailed endocytosis: an emerging feature of cancer
Mosesson, Y., Mills, G. B., & Yarden, Y. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2521 · Cited by 718
Huang, P., Qian, X., Chen, Y., Yu, L., Lin, H., Wang, L., Zhu, Y., & Shi, J. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b11846 · Cited by 666
Furuta, T., Wang, S. S.-H., Dantzker, J. L., Dore, T. M., Bybee, W. J., Callaway, E. M., Denk, W., & Tsien, R. Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1193 · Cited by 635
Prasad, P., Gordijo, C. R., Abbasi, A. Z., Maeda, A., Ip, A., Rauth, A. M., DaCosta, R. S., & Wu, X. Y. (2014) · ACS Nano · doi:10.1021/nn405773r · Cited by 630
Beyond tumorigenesis: cancer stem cells in metastasis
Li, F., Tiede, B., Massagué, J., & Kang, Y. (2007) · Cell Research · doi:10.1038/sj.cr.7310118 · Cited by 620
Rohwer, N., & Cramer, T. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.03.001 · Cited by 608
Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action
Edwards, D. I. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.1.9 · Cited by 606
Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
Chauhan, V. P., Stylianopoulos, T., Boucher, Y., & Jain, R. K. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114300 · Cited by 597
The Supramolecular Chemistry of Organic–Inorganic Hybrid Materials
Descalzo, A. B., Martínez‐Máñez, R., Sancenón, F., Hoffmann, K., & Rurack, K. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600734 · Cited by 591
Wang, C., Wang, J., Zhang, X., Yu, S., Wen, D., Hu, Q., Ye, Y., Bomba, H., Hu, X., Liu, Z., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan3682 · Cited by 591
JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress
Gerald, D., Berra, E., Frapart, Y. M., Chan, D. A., Giaccia, A. J., Mansuy, D., Pouysségur, J., Yaniv, M., & Mechta-Grigoriou, F. (2004) · Cell · doi:10.1016/j.cell.2004.08.025 · Cited by 588
Hypoxia-targeted drug delivery
Sharma, A., Arambula, J. F., Koo, S., Kumar, R., Singh, H., Sessler, J. L., & Kim, J. S. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00304a · Cited by 542
Cancer nanomedicines: So many papers and so few drugs!
Venditto, V. J., & Szoka, F. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.038 · Cited by 537
Mechanisms of drug release in nanotherapeutic delivery systems
Wong, P. T., & Choi, S. K. (2015) · Chemical Reviews · doi:10.1021/cr5004634 · Cited by 507
Polymeric nanomedicine for cancer therapy
Park, J. H., Lee, S., Kim, J.-H., Park, K., Kim, K., & Kwon, I. C. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.09.003 · Cited by 506
Understanding and Overcoming Major Barriers in Cancer Nanomedicine
Nie, S. (2010) · Nanomedicine · doi:10.2217/nnm.10.23 · Cited by 498
Light‐Activated Hypoxia‐Responsive Nanocarriers for Enhanced Anticancer Therapy
Qian, C., Yu, J., Chen, Y., Hu, Q., Xiao, X., Sun, W., Wang, C., Feng, P., Shen, Q., & Gu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201505869 · Cited by 466
Injectable Nano-Network for Glucose-Mediated Insulin Delivery
Gu, Z., Aimetti, A. A., Wang, Q., Dang, T. T., Zhang, Y., Veiseh, O., Cheng, H., Langer, R. S., & Anderson, D. G. (2013) · ACS Nano · doi:10.1021/nn400630x · Cited by 462
Walsh, J. C., Lebedev, A., Aten, E., Madsen, K., Marciano, L., & Kolb, H. C. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5378 · Cited by 420
Stimuli-responsive nanomaterials for therapeutic protein delivery
Lu, Y., Sun, W., & Gu, Z. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.015 · Cited by 415
Intratumoral injection of Clostridium novyi -NT spores induces antitumor responses
Roberts, N. J., Zhang, L., Janku, F., Collins, A., Bai, R.-Y., Staedtke, V., Rusk, A. W., Tung, D., Miller, M., Roix, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008982 · Cited by 400
Smart Nanocarrier Based on PEGylated Hyaluronic Acid for Cancer Therapy
Choi, K. Y., Yoon, H. Y., Kim, J.-H., Bae, S. M., Park, R.-W., Kang, Y. M., Kim, I.-S., Kwon, I. C., Choi, K., Jeong, S. Y., et al. (2011) · ACS Nano · doi:10.1021/nn202070n · Cited by 399
Niedre, M., Patterson, M. S., & Wilson, B. C. (2002) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2002)0750382dnildo2.0.co2 · Cited by 396
Tumor Redox Heterogeneity‐Responsive Prodrug Nanocapsules for Cancer Chemotherapy
Wang, J., Sun, X., Mao, W., Sun, W., Tang, J., Sui, M., Shen, Y., & Gu, Z. (2013) · Advanced Materials · doi:10.1002/adma.201300929 · Cited by 395
Nitroimidazoles and imaging hypoxia
Nunn, A., Linder, K., & Strauss, H. W. (1995) · European Journal of Nuclear Medicine · doi:10.1007/bf01081524 · Cited by 387
Integration of Nanoassembly Functions for an Effective Delivery Cascade for Cancer Drugs
Sun, Q., Sun, X., Ma, X., Zhou, Z., Jin, E., Zhang, B., Shen, Y., Van Kirk, E. A., Murdoch, W. J., Lott, J. R., et al. (2014) · Advanced Materials · doi:10.1002/adma.201401554 · Cited by 377
Chen, Z., Wang, Q., Wang, H., Zhang, L., Song, G., Song, L., Hu, J., Wang, H., Liu, J., Zhu, M., et al. (2013) · Advanced Materials · doi:10.1002/adma.201204616 · Cited by 376
Hypoxia-Sensitive Fluorescent Probes for in Vivo Real-Time Fluorescence Imaging of Acute Ischemia
Kiyose, K., Hanaoka, K., Oushiki, D., Nakamura, T., Kajimura, M., Suematsu, M., Nishimatsu, H., Yamane, T., Terai, T., Hirata, Y., et al. (2010) · Journal of the American Chemical Society · doi:10.1021/ja105937q · Cited by 373
Assessing Nanoparticle Toxicity
Love, S. A., Maurer-Jones, M. A., Thompson, J. W., Lin, Y.-S., & Haynes, C. L. (2012) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-062011-143134 · Cited by 367
Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery
Thambi, T., Deepagan, V. G., Yoon, H. Y., Han, H. S., Kim, S.-H., Son, S., Jo, D.-G., Ahn, C.-H., Suh, Y. D., Kim, K., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.022 · Cited by 359
Temperature-Controlled Uptake and Release in PNIPAM-Modified Porous Silica Nanoparticles
You, Y.-Z., Kalebaila, K. K., Brock, S. L., & Oupický, D. (2008) · Chemistry of Materials · doi:10.1021/cm703363w · Cited by 357
Tumor hypoxia: A target for selective cancer therapy
Kizaka‐Kondoh, S., Inoue, M., Harada, H., & Hiraoka, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01395.x · Cited by 352
Zhang, S., Hosaka, M., Yoshihara, T., Negishi, K., Iida, Y., Tobita, S., & Takeuchi, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3948 · Cited by 349
Sun, R. C., & Denko, N. C. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.022 · Cited by 344
Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor.
Henderson, B. W., & Fingar, V. H. (1987) · PubMed · Cited by 342
Accelerating the Translation of Nanomaterials in Biomedicine
Mitragotri, S., Anderson, D. G., Chen, X., Chow, E. K., Ho, D., Kabanov, A. V., Karp, J. M., Kataoka, K., Mirkin, C. A., Petrosko, S. H., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b03569 · Cited by 338
Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions
Anchordoquy, T. J., Barenholz, Y., Boraschi, D., Chorny, M., Decuzzi, P., Dobrovolskaia, M. A., Farhangrazi, Z. S., Farrell, D., Gabizon, A., Ghandehari, H., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b08244 · Cited by 337
The biology of the combretastatins as tumour vascular targeting agents
TOZER, G. M., KANTHOU, C., PARKINS, C. S., & HILL, S. A. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00211.x · Cited by 335
Liu, J., Liu, Y., Bu, W., Bu, J., Sun, Y., Du, J., & Shi, J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5042989 · Cited by 332
Gubernator, J. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.566552 · Cited by 325
Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
Zannella, V. E., Dal Pra, A., Muaddi, H., McKee, T. D., Stapleton, S., Sykes, J., Glicksman, R., Chaib, S., Zamiara, P., Milosevic, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1787 · Cited by 314
Lin, Q., Huang, Q., Li, C., Bao, C., Liu, Z., Li, F., & Zhu, L. (2010) · Journal of the American Chemical Society · doi:10.1021/ja103415t · Cited by 308
A New Two‐Photon‐Sensitive Block Copolymer Nanocarrier
Babin, J., Pelletier, M., Lepage, M., Allard, J., Morris, D., & Zhao, Y. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900255 · Cited by 305
Near IR Heptamethine Cyanine Dye–Mediated Cancer Imaging
Yang, X., Shi, C., Tong, R., Qian, W., Zhau, H. E., Wang, R., Zhu, G., Cheng, J., Yang, V. W., Cheng, T., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0059 · Cited by 302
Saha, S., Leung, K. C. ‐., Nguyen, T. D., Stoddart, J. F., & Zink, J. I. (2007) · Advanced Functional Materials · doi:10.1002/adfm.200600989 · Cited by 296
Development of Azo‐Based Fluorescent Probes to Detect Different Levels of Hypoxia
Piao, W., Tsuda, S., Tanaka, Y., Maeda, S., Liu, F., Takahashi, S., Kushida, Y., Komatsu, T., Ueno, T., Terai, T., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201305784 · Cited by 293
Enhancing the Migration Ability of Mesenchymal Stromal Cells by Targeting the SDF-1/CXCR4 Axis
Marquez-Curtis, L. A., & Janowska-Wieczorek, A. (2013) · BioMed Research International · doi:10.1155/2013/561098 · Cited by 287
Cai, X., Gao, W., Ma, M., Wu, M., Zhang, L., Zheng, Y., Chen, H., & Shi, J. (2015) · Advanced Materials · doi:10.1002/adma.201503381 · Cited by 279
Choi, K. Y., Min, K. H., Na, J. H., Choi, K., Kim, K., Park, J. H., Kwon, I. C., & Jeong, S. Y. (2009) · Journal of Materials Chemistry · doi:10.1039/b900456d · Cited by 272
Liu, H., Liu, S., Li, Y., Wang, X., Xue, W., Ge, G., & Luo, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034608 · Cited by 262
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Kirtane, A. R., Kalscheuer, S. M., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 258
Park, K., Kim, J.-H., Nam, Y. S., Lee, S., Nam, H. Y., Kim, K., Park, J. H., Kim, I.-S., Choi, K., Kim, S. Y., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.009 · Cited by 257
Bacteria-Mediated Hypoxia-Specific Delivery of Nanoparticles for Tumors Imaging and Therapy
Luo, C.-H., Huang, C.-T., Su, C.-H., & Yeh, C.-S. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00262 · Cited by 256
Significance of nitroimidazole compounds and hypoxia‐inducible factor‐1 for imaging tumor hypoxia
Kizaka‐Kondoh, S., & Konse‐Nagasawa, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01195.x · Cited by 255
Stretch-Triggered Drug Delivery from Wearable Elastomer Films Containing Therapeutic Depots
Di, J., Yao, S., Ye, Y., Cui, Z., Yu, J., Ghosh, T. K., Zhu, Y., & Gu, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b03975 · Cited by 253
Sullivan, R., Paré, G. C., Frederiksen, L. J., Semenza, G. L., & Graham, C. H. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0198 · Cited by 243
Fate and Toxicity of Metallic and Metal‐Containing Nanoparticles for Biomedical Applications
Li, Y., & Chen, C. (2011) · Small · doi:10.1002/smll.201101059 · Cited by 236
Hypoxia‐Targeted siRNA Delivery
Perche, F., Biswas, S., Wang, T., Zhu, L., & Torchilin, V. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308368 · Cited by 234
Biomedical nanomaterials for imaging-guided cancer therapy
Huang, Y., He, S., Cao, W., Cai, K., & Liang, X.-J. (2012) · Nanoscale · doi:10.1039/c2nr31715j · Cited by 233
Cui, L., Zhong, Y., Zhu, W., Xu, Y., Du, Q., Wang, X., Qian, X., & Xiao, Y. (2011) · Organic Letters · doi:10.1021/ol102975t · Cited by 227
Li, Z., Li, X., Gao, X., Zhang, Y., Shi, W., & Ma, H. (2013) · Analytical Chemistry · doi:10.1021/ac400750r · Cited by 225
Photochemical internalisation in drug and gene delivery
Høgset, A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.016 · Cited by 223
Kumar, R., Han, J., Lim, H.-J., Ren, W. X., Lim, J.-Y., Kim, J.-H., & Kim, J. S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja510421q · Cited by 214
Nanomaterials for Cancer Precision Medicine
Wang, Y., Sun, S., Zhang, Z., & Shi, D. (2018) · Advanced Materials · doi:10.1002/adma.201705660 · Cited by 212
NIR‐Responsive On‐Demand Release of CO from Metal Carbonyl‐Caged Graphene Oxide Nanomedicine
He, Q., Kiesewetter, D. O., Qu, Y., Fu, X., Fan, J., Huang, P., Liu, Y., Zhu, G., Liu, Y., Qian, Z., et al. (2015) · Advanced Materials · doi:10.1002/adma.201502762 · Cited by 211
Wu, Y.-S., Ngai, S.-C., Goh, B.-H., Chan, K.-G., Lee, L.-H., & Chuah, L.-H. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00761 · Cited by 210
Enzyme Sensitive Synthetic Polymer Micelles Based on the Azobenzene Motif
Rao, J., & Khan, A. (2013) · Journal of the American Chemical Society · doi:10.1021/ja407514z · Cited by 207
Hypoxic tumor microenvironment: Opportunities to develop targeted therapies
Patel, A., & Sant, S. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.04.005 · Cited by 201
Yasuda, H. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.026 · Cited by 198
Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity
ZHANG, J., LIU, F., & HUANG, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.004 · Cited by 195
Polymer‐Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications
Jen, M. C., Serrano, M. C., van Lith, R., & Ameer, G. A. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201101707 · Cited by 194
Regulation of endocytosis via the oxygen-sensing pathway
Wang, Y., Roche, O., Yan, M. S., Finak, G., Evans, A. J., Metcalf, J. L., Hast, B. E., Hanna, S. C., Wondergem, B., Furge, K. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1922 · Cited by 192
Schade, B., Hagen, V., Schmidt, R., Herbrich, R., Krause, E., Eckardt, T., & Bendig, J. (1999) · The Journal of Organic Chemistry · doi:10.1021/jo9910233 · Cited by 189
The Clinical Significance of Hypoxia in Human Cancers
Dhani, N., Fyles, A., Hedley, D., & Milosevic, M. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2014.11.002 · Cited by 188
Photodynamic therapy induced vascular damage: an overview of experimental PDT
Wang, W., Moriyama, L. T., & Bagnato, V. S. (2013) · Laser Physics Letters · doi:10.1088/1612-2011/10/2/023001 · Cited by 186
Functionalized Nanoscale Micelles Improve Drug Delivery for Cancer Therapy in Vitro and in Vivo
Wei, T., Liu, J., Ma, H., Cheng, Q., Huang, Y., Zhao, J., Huo, S., Xue, X., Liang, Z., & Liang, X.-J. (2013) · Nano Letters · doi:10.1021/nl400586t · Cited by 183
Clinical implications of high NQO1 expression in breast cancers
Yang, Y., Zhang, Y., Wu, Q., Cui, X., Lin, Z., Liu, S., & Chen, L. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-14 · Cited by 181
Metabolic Profiling of Hypoxic Cells Revealed a Catabolic Signature Required for Cell Survival
Frezza, C., Zheng, L., Tennant, D. A., Papkovsky, D. B., Hedley, B. A., Kalna, G., Watson, D. G., & Gottlieb, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024411 · Cited by 177
Neural Stem Cell Tropism to Glioma: Critical Role of Tumor Hypoxia
Zhao, D., Najbauer, J., Garcia, E., Metz, M. Z., Gutova, M., Glackin, C. A., Kim, S. U., & Aboody, K. S. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0146 · Cited by 175
Waite, C. L., & Roth, C. M. (2012) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.v40.i1.20 · Cited by 175
Zuo, H., Tao, J., Shi, H., He, J., Zhou, Z., & Zhang, C. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.09.017 · Cited by 170
Okuda, K., Okabe, Y., Kadonosono, T., Ueno, T., Youssif, B. G. M., Kizaka-Kondoh, S., & Nagasawa, H. (2012) · Bioconjugate Chemistry · doi:10.1021/bc2004704 · Cited by 169
Semenza, G. L. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9058-y · Cited by 169
The role of hypoxia-activated prodrugs in cancer therapy
Denny, W. A. (2000) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00006-1 · Cited by 167
Kalluru, P., Vankayala, R., Chiang, C., & Hwang, K. C. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201307358 · Cited by 166
Span, P. N., & Bussink, J. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2014.10.002 · Cited by 163
Lin, Q., Bao, C., Yang, Y., Liang, Q., Zhang, D., Cheng, S., & Zhu, L. (2013) · Advanced Materials · doi:10.1002/adma.201204455 · Cited by 163
Wang, P., Li, X., Yao, C., Wang, W., Zhao, M., El-Toni, A. M., & Zhang, F. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.017 · Cited by 160
Niedermayer, S., Weiß, V., Herrmann, A., Schmidt, A., Datz, S., Müller, K., Wagner, E., Bein, T., & Bräuchle, C. (2015) · Nanoscale · doi:10.1039/c4nr07245f · Cited by 154
Palanikumar, L., Choi, E. S., Cheon, J. Y., Joo, S. H., & Ryu, J. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201402755 · Cited by 150
Vaupel, P. W., & Mayer, A. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0620-8_3 · Cited by 147
Programmable nanomedicine: synergistic and sequential drug delivery systems
Pacardo, D. B., Ligler, F. S., & Gu, Z. (2015) · Nanoscale · doi:10.1039/c4nr07677j · Cited by 144
Hypoxia-Responsive Polymersomes for Drug Delivery to Hypoxic Pancreatic Cancer Cells
Kulkarni, P., Haldar, M. K., You, S., Choi, Y., & Mallik, S. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b00350 · Cited by 144
High selectivity imaging of nitroreductase using a near-infrared fluorescence probe in hypoxic tumor
Xu, K., Wang, F., Pan, X., Liu, R., Ma, J., Kong, F., & Tang, B. (2013) · Chemical Communications · doi:10.1039/c3cc38980d · Cited by 143
Hua, L., Wang, Z., Zhao, L., Mao, H., Wang, G., Zhang, K., Liu, X., Wu, D., Zheng, Y., Lu, J. L., et al. (2018) · Theranostics · doi:10.7150/thno.26225 · Cited by 143
Breast cancer stem cells: implications for therapy of breast cancer
Morrison, B. J., Schmidt, C., Lakhani, S. R., Reynolds, B. A., & López, J. A. (2008) · Breast Cancer Research · doi:10.1186/bcr2111 · Cited by 140
Thambi, T., Yoon, H. Y., Kim, K., Kwon, I. C., Yoo, C. K., & Park, J. H. (2011) · Bioconjugate Chemistry · doi:10.1021/bc2000963 · Cited by 138
Oxygen dependence of hematoporphyrin derivative-induced photoinactivation of Chinese hamster cells.
Mitchell, J. B., McPherson, S., DeGraff, W., Gamson, J., Zabell, A., & Russo, A. (1985) · PubMed · Cited by 136
Takahashi, S., Piao, W., Matsumura, Y., Komatsu, T., Ueno, T., Terai, T., Kamachi, T., Kohno, M., Nagano, T., & Hanaoka, K. (2012) · Journal of the American Chemical Society · doi:10.1021/ja310049d · Cited by 133
Monoamine Oxidase A Inhibitor–Near-Infrared Dye Conjugate Reduces Prostate Tumor Growth
Wu, B. J., Lin, T., Gallagher, J. D., Kushal, S., Chung, L. W. K., Zhau, H. E., Olenyuk, B. Z., & Shih, J. C. (2015) · Journal of the American Chemical Society · doi:10.1021/ja512613j · Cited by 132
Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview
Lungu, I. I., Grumezescu, A. M., Volceanov, A., & Andronescu, E. (2019) · Molecules · doi:10.3390/molecules24193547 · Cited by 129
Zhu, J., Niu, Y., Li, Y., Gong, Y., Shi, H., Huo, Q., Liu, Y., & Xu, Q. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb03066a · Cited by 126
Quantifying Transient Hypoxia in Human Tumor Xenografts by Flow Cytometry
Bennewith, K. L., & Durand, R. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0289 · Cited by 125
Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines
Omidi, Y., & Barar, J. (2014) · PubMed Central · doi:10.5681/bi.2014.021 · Cited by 123
Li, Y., Lu, A., Long, M., Cui, L., Chen, Z., & Zhu, L. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.10.029 · Cited by 122
Polymer-coated mesoporous silica nanoparticles for the controlled release of macromolecules
Bhattacharyya, S., Wang, H., & Ducheyne, P. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.06.003 · Cited by 120
Hypoxia inducible factor-1: a novel target for cancer therapy
Belozerov, V. E., & Meir, E. G. V. (2005) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000180116.85912.69 · Cited by 120
Feng, Q., Li, Y., Yang, X., Zhang, W., Hao, Y., Zhang, H., Hou, L., & Zhang, Z. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.011 · Cited by 120
Poly(amidoamine) dendrimer complexes as a platform for gene delivery
Shcharbin, D., Shakhbazau, A., & Bryszewska, M. J. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.853661 · Cited by 112
Natural products in the discovery of novel sonosensitizers
Pang, X., Xu, C., Jiang, Y., Xiao, Q., & Leung, A. W. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.12.004 · Cited by 111
Targeting hypoxic tumour cells to overcome metastasis
Bennewith, K. L., & Dedhar, S. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-504 · Cited by 109
Wu, B. J., Shao, C., Li, X., Shi, C., Li, Q., Hu, P., Chen, Y., Dou, X., Sahu, D., Li, W., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.073 · Cited by 107
Qiu, J., Xiao, Q., Zheng, X., Zhang, L., Xing, H., Ni, D., Liu, Y., Zhang, S., Ren, Q., Hua, Y., et al. (2015) · Nano Research · doi:10.1007/s12274-015-0858-z · Cited by 106
Selective cancer treatment via photodynamic sensitization of hypoxia-responsive drug delivery
He, H., Zhu, R., Sun, W., Cai, K., Chen, Y., & Yin, L. (2017) · Nanoscale · doi:10.1039/c7nr07677k · Cited by 100
Leveraging H2O2Levels for Biomedical Applications
Wang, J., Zhang, Y., Ogunnaike, E. A., Ligler, F. S., & Gu, Z. (2017) · Advanced Biosystems · doi:10.1002/adbi.201700084 · Cited by 99
A multifunctional heptamethine near-infrared dye for cancer theranosis
Luo, S., Tan, X., Qi, Q., Guo, Q., Ran, X., Zhang, L., Zhang, E., Liang, Y., Weng, L., Hu, Z., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.057 · Cited by 98
Optical Imaging of Kidney Cancer with Novel Near Infrared Heptamethine Carbocyanine Fluorescent Dyes
Yang, X., Shao, C., Wang, R., et al. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.09.056 · Cited by 92
A turn-on fluorescent probe for tumor hypoxia imaging in living cells
Cai, Q., Yu, T., Zhu, W. P., Xu, Y. F., & Qian, X. H. (2015) · Chemical Communications · doi:10.1039/c5cc05518k · Cited by 91
PL–W18O49–TPZ Nanoparticles for Simultaneous Hypoxia-Activated Chemotherapy and Photothermal Therapy
Zhao, P., Ren, S., Liu, Y., Huang, W., Zhang, C., & He, J. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b17323 · Cited by 91
Preparation of bifunctional hybrid mesoporous silica potentially useful for drug targeting
Pasqua, L., Testa, F., Aiello, R., Cundari, S., & Nagy, J. B. (2007) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2007.01.045 · Cited by 90
Bioreducible polymersomes for intracellular dual-drug delivery
Thambi, T., Deepagan, V. G., Ko, H., Lee, D. S., & Park, J. H. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm34546c · Cited by 89
Design of a bioreductively-activated fluorescent pH probe for tumor hypoxia imaging
Nakata, E., Yukimachi, Y., Kariyazono, H., Im, S., Abe, C., Uto, Y., Maezawa, H., Hashimoto, T., Okamoto, Y., & Hori, H. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.08.037 · Cited by 85
Thambi, T., Deepagan, V. G., Yoo, C., & Park, J. H. (2011) · Polymer · doi:10.1016/j.polymer.2011.08.024 · Cited by 85
Chung, U. S., Kim, J.-H., Kim, B., Kim, E., Jang, W., & Koh, W. (2015) · Chemical Communications · doi:10.1039/c5cc09149g · Cited by 80
Engineering oxygen nanobubbles for the effective reversal of hypoxia
Khan, M. S., Hwang, J., Seo, Y., Shin, K., Lee, K., Park, C., Choi, Y., Hong, J. W., & Choi, J. H. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1492420 · Cited by 77
Bao, C., Fan, G., Lin, Q., Li, B., Cheng, S., Huang, Q., & Zhu, L. (2011) · Organic Letters · doi:10.1021/ol203188h · Cited by 76
Xie, Z., Guo, W.-W., Guo, N., Huang-Fu, M.-Y., Liu, H., Lin, M., Xu, W., Chen, J., Wang, T., Wei, Q., et al. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.03.013 · Cited by 76
Komatsu, H., Harada, H., Tanabe, K., Hiraoka, M., & Nishimoto, S. (2010) · MedChemComm · doi:10.1039/c0md00024h · Cited by 75
Carboxymethyl dextran-based hypoxia-responsive nanoparticles for doxorubicin delivery
Son, S., Rao, N. V., Ko, H., Shin, S., Jeon, J., Han, H. S., Nguyen, V. Q., Thambi, T., Suh, Y. D., & Park, J. H. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.11.048 · Cited by 75
Hodgkiss, R. J., Jones, G., Long, A., PARRICK, J., Smith, K., Stratford, M., & Wilson, G. D. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.24 · Cited by 73
Recent Progress in the Design of Hypoxia‐Specific Nano Drug Delivery Systems for Cancer Therapy
Sahu, A., Choi, W. I., & Tae, G. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800026 · Cited by 73
Hypoxic Tumors and Their Effect on Immune Cells and Cancer Therapy
Yotnda, P., Wu, D., & Swanson, A. M. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-786-0_1 · Cited by 70
A redox-activated theranostic nanoagent: toward multi-mode imaging guided chemo-photothermal therapy
Zhang, T., Xu, C.-H., Zhao, W., Gu, Y., Li, X., Xu, J., & Chen, H. (2018) · Chemical Science · doi:10.1039/c8sc02446d · Cited by 69
Questions on the role of the EPR effect in tumor targeting
Park, K. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.001 · Cited by 67
Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapy
Ambasta, R. K., Sharma, A., & Kumar, P. (2011) · Vascular Cell · doi:10.1186/2045-824x-3-26 · Cited by 66
Liapis, V., Labrinidis, A., Zinonos, I., Hay, S. J., Ponomarev, V., Panagopoulos, V., DeNichilo, M. O., Ingman, W. V., Atkins, G. J., Findlay, D. M., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.020 · Cited by 64
Cited by
Conquering the Hypoxia Limitation for Photodynamic Therapy
Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705
Gavilán, H., Avugadda, S. K., Fernández-Cabada, T., Soni, N., Cassani, M., Mai, B. T., Chantrell, R., & Pellegrino, T. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00427a · Cited by 525
Moradi Kashkooli, F., Soltani, M., & Souri, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.012 · Cited by 514
Theranostic Fluorescent Probes
Sharma, A., Verwilst, P., Li, M., Ma, D., Singh, N., Yoo, J., Kim, Y., Yang, Y., Zhu, J.-H., Huang, H., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00778 · Cited by 499
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Peng, S., Xiao, F., Chen, M., & Gao, H. (2022) · Advanced Science · doi:10.1002/advs.202103836 · Cited by 441
Metadata
- Authors
- Kumari, R., Sunil, D., & Ningthoujam, R. S.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 319
- Pages
- 135-156
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2997383418
- Cited by
- 263
- References
- 226
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.